Cincinnati Children’s Hospital Medical Center and Orange Grove Bio Establish Collaboration to Develop and Commercialize Novel Therapeutics
March 09, 2022 06:30 ET
|
Orange Grove Bio
CINCINNATI, March 09, 2022 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Children’s Hospital Medical Center today announced the...
7 Hills Pharma’s Clinical-stage Novel Immunostimulant 7HP349 Granted FDA Fast Track Designation for Anti-PD-1-resistant Metastatic Melanoma
March 08, 2022 17:32 ET
|
7 Hills Pharma
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC (“7 Hills” or “7HP”), a clinical-stage drug development company bringing to market a platform of unique, first-in-class oral small...
Psychedelic Healthcare VC Fund Palo Santo to Participate as Panelists at SXSW Conference
February 24, 2022 10:54 ET
|
Palo Santo
CHICAGO and NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a leading psychedelic healthcare investment fund, will participate in two of the six panels devoted to psychedelic medicine in...
Metabolon Announces Chief Financial Officer Transition
February 14, 2022 08:37 ET
|
Metabolon
MORRISVILLE, N.C., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces the appointment of Gerald M. Haines II as Chief Financial Officer (CFO), as current...
Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs
February 07, 2022 04:30 ET
|
Nemysis Limited
DUBLIN, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Nemysis Ltd today announces the appointment of Antonino Santoro to its Executive Team as Adviser for Scientific Affairs. Antonino Santoro is a Chemist,...
Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego
January 19, 2022 07:00 ET
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
PharmaCord Appoints Beth Roberts to Vice President, Administration
January 18, 2022 08:30 ET
|
PharmaCord, Inc.
JEFFERSONVILLE, Ind., Jan. 18, 2022 (GLOBE NEWSWIRE) -- PharmaCord, LLC, a rapidly growing provider of patient services and other commercialization solutions to life science companies, announced...
Monthly information on share capital and company voting rights
January 11, 2022 16:30 ET
|
Cellectis Inc.
NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting...
Recro Reports Inducement Grants For New Staff
January 06, 2022 16:05 ET
|
Recro Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Aceragen Announces $3.5 Million Development Award from Cystic Fibrosis Foundation to Progress Novel Therapy for CF-Related Exacerbations
January 06, 2022 09:00 ET
|
Aceragen
Raleigh-Durhan, NC, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Aceragen, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for orphan diseases with high unmet medical need, today...